Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

2,610 public trials 494 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

NCT00014508

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Baptist Cancer Institute - Jacksonville Jacksonville, Florida, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Cancer Center at Tufts - New England Medical Center Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis

NCT00003353

Conditions
Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Sylvester Cancer Center, University of Miami Miami, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • CCOP - Evanston Evanston, Illinois, United States
View all 17 locations
View Trial Details
Completed

VMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple Myeloma

NCT04151615

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Soonchunhyang University Bucheon hospital Bucheon-si, South Korea
  • Inje university Haeundae Paik Hospital Busan, South Korea
  • Kosin University Gospel hospital Busan, South Korea
  • Pusan national University Hospital Busan, South Korea
View all 24 locations
View Trial Details
Completed

A Study of Evaluating the Safety and Efficacy of ATG-010 in Relapsed Refractory Multiple Myeloma

NCT03944057

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Beijing Chao-Yang Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Guangdong Provincial Peoples Hospital Guangzhou, Guangdong, China
  • Nanfang Hospital Guangzhou, Guangdong, China
View all 17 locations
View Trial Details
Completed

A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on Panobinostat

NCT04150289

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • American Health Network Indiana Indianapolis, Indiana, United States
  • Southern Nevada Cancer Research Foundation and Optum Cancer Care Las Vegas, Nevada, United States
  • Oncology Specialists of Charlotte Charlotte, North Carolina, United States
  • Southern Oncology Specialists Huntersville, North Carolina, United States
View Trial Details
Completed

NKTR-255 in Relapsed/Refractory Multiple Myeloma & Non-Hodgkin Lymphoma

NCT04136756

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +21 more
Locations
  • Western Regional Medical Center - CTCA Goodyear, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 13 locations
View Trial Details
Completed

Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT00002878

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University of California San Diego Cancer Center La Jolla, California, United States
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • CCOP - Christiana Care Health Services Wilmington, Delaware, United States
  • Walter Reed Army Medical Center Washington D.C., District of Columbia, United States
View all 40 locations
View Trial Details

Related conditions